NET PROFIT (x1000 DKK)
EMPLOYEES
Infant Bacterial Therapeutics AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
196 |
| Earnings before taxes |
-88,914
|
-82,660
|
-43,737 |
| EBITDA |
-94,394
|
-90,419
|
-43,975 |
| Total assets |
155,588
|
235,982
|
233,627 |
| Current assets |
149,772
|
229,419
|
226,552 |
| Current liabilities |
45,009
|
31,018
|
11,970 |
| Equity capital |
110,579
|
204,964
|
221,657 |
| - share capital |
2,385
|
2,466
|
2,045 |
| Employees (average) |
10
|
8
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
71.1%
|
86.9%
|
94.9% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-57.1%
|
-35.0%
|
-18.6% |
| Current ratio |
332.8%
|
739.6%
|
1892.7% |
| Return on equity (ROE) |
-80.4%
|
-40.3%
|
-19.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
2
|
1
|
-1 |
| Chg. No. of employees % |
25%
|
14%
|
-13% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.